CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company
Protalix BioTherapeutics, Inc.
Sign in to watch- Ticker
- PLX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650643773
- Phone
- 201-696-9345
- Business address
- 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-19 | Camber Capital Management LLC 10% owner | Purchase | +423 | $1.03 | $436 | 13,275,000 |
| 2015-03-23 | Maimon Yossi VP, Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2015-03-23 | Shaaltiel Yoseph Executive VP, R&D | Grant or award · Stock Options (Right to Buy) | +275,000 | 275,000 | ||
| 2015-03-23 | Palash Tzvi Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +125,000 | 125,000 | ||
| 2015-03-23 | Almon Einat Brill SVP, Product Development | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2014-10-02 | Bronfeld Zeev Director | Other disposition | −1,509,948 | 0 | ||
| 2014-10-02 | Bronfeld Zeev Director | Other acquisition | +324,372 | 2,162,481 | ||
| 2014-09-29 | Manor Moshe President & CEO | Grant or award · Stock Options (Right to Buy) | +900,000 | 900,000 | ||
| 2014-09-16 | Bronfeld Zeev Director | Other disposition | −8,556,371 | 1,509,948 | ||
| 2014-09-16 | Bronfeld Zeev Director | Other acquisition | +1,838,109 | 1,838,109 | ||
| 2014-09-16 | Bio-Cell Ltd 10% owner | Other disposition | −8,556,371 | 1,509,948 | ||
| 2014-08-13 | Bronfeld Zeev Director | Sale | −4,400,000 | $2.47 | $10.9M | 10,066,319 |
| 2014-08-13 | Bio-Cell Ltd 10% owner | Sale | −4,400,000 | $2.47 | $10.9M | 10,066,319 |
| 2014-07-24 | Yanai Shlomo Director | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2013-08-15 | Akirov Alfred Director | Sale | −2,330 | $5.07 | $12K | 4,915,383 |
| 2013-08-14 | Akirov Alfred Director | Sale | −100,000 | $5.05 | $505K | 4,927,713 |
| 2013-08-14 | Akirov Alfred Director | Sale | −5,000 | $5.07 | $25K | 4,922,713 |
| 2013-08-14 | Akirov Alfred Director | Sale | −5,000 | $5.08 | $25K | 4,917,713 |
| 2013-03-12 | Akirov Alfred Director | Sale | −10,000 | $5.70 | $57K | 5,027,713 |
| 2013-03-11 | Akirov Alfred Director | Sale | −300 | $5.79 | $2K | 5,055,713 |
Page 6 of 7 · 139 trades